Showing results (261-270 of 439) with videos related to

Sort By:
Pageof 44
The Canadian Journal of Cardiology|July 13, 2024
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic ApproachesJohn W Eikelboom, Qilong Yi, William F McIntyre, et al.
JAMA Cardiology|October 2, 2024
Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical TrialMartino Martinelli-Filho, José A Marin-Neto, Mauricio Ibrahim Scanavacca, et al.
JACC. Heart Failure|June 7, 2022
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-PreservedJames L Januzzi, Javed Butler, Faiez Zannad, et al.
European Heart Journal|December 8, 2022
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Bhm, Stefan Anker, Felix Mahfoud, et al.
European Journal of Heart Failure|September 16, 2025
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-ReducedMichael Böhm, Javed Butler, Amr Abdin, et al.
European Journal of Heart Failure|February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programmeNathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The American Journal of Cardiology|September 28, 2011
Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials)Peter Damman, Lene Holmvang, Jan G P Tijssen, et al.
American Heart Journal|October 8, 2013
Learning from recent trials and shaping the future of acute heart failure trialsRobert J Mentz, Gary Michael Felker, Tariq Ahmad, et al.
JACC. Cardiovascular Interventions|February 25, 2012
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) TrialsPeter Damman, Nan van Geloven, Lars Wallentin, et al.
Pageof 44